Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Thrombophilic Risk Factors in Pediatric Patients Diagnosed at the Ha'Emek Medical Center

This study has been completed.
Information provided by (Responsible Party):
Dr Koren Ariel, HaEmek Medical Center, Israel Identifier:
First received: August 14, 2008
Last updated: August 25, 2011
Last verified: August 2011

The study will assess the clinical and laboratory data of about 100 pediatric patients diagnosed and treated at the Pediatric Hematology Unit during the years 1980 until 2007 because of thrombotic events.

The results, the treatment given, and the outcome of the patients will be summarized.

Condition Intervention
Other: Observational

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Retrospective
Official Title: The Study Will Summarize the Clinical and Laboratory Data of All the Pediatric Patients Diagnosed With Thrombotic Events at the Pediatric Hematology Unit

Resource links provided by NLM:

Further study details as provided by HaEmek Medical Center, Israel:

Estimated Enrollment: 100
Study Start Date: May 2008
Study Completion Date: August 2009
Primary Completion Date: August 2009 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
Patients with thromboembolic events
Other: Observational
Data summary only


Ages Eligible for Study:   up to 20 Years   (Child, Adult)
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
The population cohort will include about 100 patients diagnosed with thrombotic events at the Pediatric Hematology Unit

Inclusion Criteria:All the patients diagnosed since 1980.

Exclusion Criteria:Patients with insufficient data records.

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00736008

Pediatric Hematology Unit - Ha'Emek Medical Center
Afula, Israel, 18101
Sponsors and Collaborators
HaEmek Medical Center, Israel
Principal Investigator: Carina Levin, MD Pediatric Hematology Unit - Ha'Emek Medical Center - Afula - 18101 - Israel
Principal Investigator: Ayala Mari, Student Pediatric Dpt B - Ha'Emek Medical Center - Afula - Israel
  More Information

Responsible Party: Dr Koren Ariel, Head of Pediatric Hematology Unit and Pediatric Dpt B, HaEmek Medical Center, Israel Identifier: NCT00736008     History of Changes
Other Study ID Numbers: 0020-08-EMC 
Study First Received: August 14, 2008
Last Updated: August 25, 2011
Health Authority: Israel: Ministry of Health

Keywords provided by HaEmek Medical Center, Israel:
Factor V Leiden
Prothrombin Mutation

Additional relevant MeSH terms:
Embolism and Thrombosis
Vascular Diseases
Cardiovascular Diseases processed this record on October 20, 2016